LifeMD vs. Trimi: prices, fine print, and the honest verdict

Tirzepatide pricing

LifeMD: $597 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $149/mo membership. Trimi carries only a reported figure — $125/mo from a competing comparison site (May 2026), never captured on a provider page — so it is listed, reviewed, and excluded from ranked comparisons pending verification.

Semaglutide pricing

Only LifeMD publishes a semaglutide price here: Semaglutide runs $348 a month all-in. Trimi doesn't sell compounded semaglutide.

Transparency

LifeMD: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. Trimi: Third-party-reported; dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

LifeMD: program fee recurs monthly; program fee recurs until cancelled; $149/mo membership recurs until cancelled. Trimi: terms not published.

Two ladders, side by side

Put both dose ladders on the same axis and the structures argue for themselves: LifeMD holds $597 on every rung (four-month titration: exactly $2,388). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

The semaglutide board

Only LifeMD fields a verified semaglutide price here — $348/month all-in (#19 of 19) — while Trimi publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. LifeMD's ranked figure is $597 ($448 medication + $149 mandatory membership); Trimi's reported $125 can't be normalized because no source page confirms what it includes. 2 · Maintenance basis. LifeMD is dose-flat, so its entry and 10 mg figures coincide. 3 · Terms separated. LifeMD: standing $597, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. LifeMD: third-party-reported, read 2026-08-05; Trimi: third-party-reported. 5 · Pharmacy weighed. LifeMD names no pharmacy; Trimi names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

LifeMD: a mandatory $149/mo membership folded into our all-in figure; program fee recurs until cancelled; commitment: program fee recurs monthly. Trimi: no membership — the medication figure is the billed figure. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

LifeMD carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Trimi carries third-party-reported pricing; its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from LifeMD to Trimi (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: LifeMD: shipping included; consultation video visits included in program fee; video visit model. Trimi: shipping, consult, and refill logistics aren’t published in our capture — ask at intake, in writing. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick LifeMD if you want a price that survives titration; you want the insurance paperwork done for you. Pick Trimi if you refuse membership fees on principle. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Trimi, ranking would require: a provider-page capture confirming the reported $125 figure and exactly what it includes; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are Eden at $408 (dose-scaled, $99 membership included); MEDVi at $399 (flat, no membership); Remedy Meds at $399 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The brand benchmark both must beat

Neither program exists in a vacuum: FDA-approved Zepbound sits at $449/month at maintenance (LillyDirect or retail KwikPens, ~$350 on TrumpRx, ~$50 for newly eligible Medicare patients), and Wegovy at a flat $349. The cheaper of these two compounded options saves $-1,776/year against the Zepbound benchmark — the number that has to justify accepting a not-FDA-reviewed product, per the full trade analysis. When a compounded quote drifts above ~$350, this benchmark starts winning the argument on its own.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.